GlaxoSmithKline plc Financials

Market Capitalization £55.44 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	22.19
Forward PE	8.06
Price to Sales TTM	£1.77
Price to Book MRQ	£394.29
Enterprise to Revenue	2.16
Enterprise to EBITDA	7.30

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	8.02%
Operating Margin	8.33%
Return on Assets TTM	7.24%
Return on Equity TTM	21.85%

Income Statement

Revenue TTM	£31,310,999,552
Revenue per Share TTM	£7.69
Quarterly Revenue Growth	-1.70%
Gross Profit TTM	£22,665,000,960
EBITDA	£7,248,000,000
Net Income to Common TTM	£2,511,000,064
Diluted EPS TTM	£0.61
Quarterly Earnings Growth YoY	-1.66%

Balance Sheet

Total Cash MRQ	£3,212,000,000
Total Cash per Share MRQ	£0.79
Total Debt MRQ	£
Total Debt to Equity MRQ	119.37
Current Ratio MRQ	0.81
Book Value per Share MRQ	£3.43

Cash Flow

Operating Cash Flow TTM	£7,421,000,192
Levered Free Cash Flow TTM	£6,040,500,224

GSK Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	4,080,529,920
Float Shares	3,949,970,400
Avg 10 Volume	5,549,933
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	1.60%
% Held by Institutions	44.93%

Stock Price Summary

Beta	0.33
Fifty Two Week Low	£1282.50
Fifty Two Week High	£1823.50
Fifty Two Week Change	-13.06%
Day 50 MA	£1341.50
Day 200 MA	£1526.19

Dividends and Splits

Forward Annual Dividend Rate	£60.00
Forward Annual Dividend Yield	4.42%
Trailing Annual Dividend Rate	£61.00
Trailing Annual Dividend Yield	4.50%
Payout Ratio	98.85%
Dividend Date
Ex Dividend Date	2024-11-14
Last Split Factor
Last Split Date	2022-07-19